your market intelligence analyst
Search Results
994 results
Your search is now limited to «Immunotherapy» expert search. 08/05/2020 02:51
Aug 5 2020 Over a thousand oncology clinical trials have been suspended due to Covid putting back research which is vital for patients across the world.
More from
HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production.
More from International Journal of COPD:
Business Wire 08/04/2020 11:00
ABOUT AML and CMML AML, the most common acute leukemia (blood and bone marrow cancer) in adults, is characterized by the proliferation of abnormal myeloblasts (a type of white blood cell) in the bone marrow.
More from Business Wire: 08/04/2020 07:10
A team of Princess Margaret Cancer Centre scientists and clinicians addressed this question with a novel study evaluating various cancer patients' response to a specific immunotherapy drug via a customized test based on each patient's tumor profile.
More from 08/04/2020 04:27
Global Dendritic Cell and Tumor Cell Vaccines Market Cancer is caused due to an abnormal growth of cells in the body, which is also known as malignancy.
More from
Research publications using B16 melanoma clones sourced from his laboratory at MD Anderson are still among the most cited in the metastasis literature.
More from Cancer Research - Recent Issues (abstracts): 08/03/2020 23:46
Cancer immunotherapies make use of the ability of the immune system to attack cancer cells: they unleash the killer function of T cells, which then attack and eradicate the cancer cells.
More from
PR Newswire 08/03/2020 11:20
The prospective phase II INSPIRE study, led by the Princess Margaret Cancer Centre in Toronto , followed patients with advanced solid tumors being treated with the immunotherapy drug, pembrolizumab.
More from PR Newswire:
Pharmaceutical Journal 08/03/2020 11:12
Writing in the Annals of Oncology on 31 July 2020, members of the European Society for Medical Oncology (ESMO) said that at the start of the pandemic, patients with cancer were seen as particularly vulnerable, which led to “sweeping changes” in cancer management, including “abbreviation of radiotherapy, switching from intravenous to oral chemotherapy ...
More from Pharmaceutical Journal:
Benzinga 08/03/2020 11:12
Georgia Oncology and Hematology Consultants (GOHC) is providing care at its new clinic located at 1111 Glynco Parkway, Suite 35 in Brunswick.
More from Benzinga:
SynBioBeta 08/03/2020 09:17
HER2 is overexpressed not only in breast and gastroesophageal cancers, but in a wide variety of epithelial origin solid tumors, such as non-small cell lung, colorectal, bladder, and pancreatic cancers,” said Debora Barton , MD, Chief Medical Officer at CARISMA Therapeutics.
More from SynBioBeta:
NoCamels (Israel) 08/03/2020 09:00
Israel’s Teva Pharmaceutical Industries is partnering with the Technion-Israel Institute of Technology for research into new immunotherapy methods to treat cancer and diseases of the nervous system.
More from NoCamels (Israel):
GlobeNewswire 08/03/2020 08:00
The company’s individualized neoantigen-based immunotherapy, GRANITE, and its “off the shelf” shared neoantigen-based immunotherapy, SLATE, are being evaluated in clinical studies.
More from GlobeNewswire:
The review was also conducted under Project Orbis, an initiative of the FDA Oncology Center of Excellence that provides a framework for concurrent submission and review of oncology products among international partners.
More from Pharmaceutical Business Review:
Pharmafile 08/03/2020 07:09
This treatment is currently approved for certain types of lymphoma and leukaemia patients.
More from Pharmafile:
AsiaOne 08/03/2020 07:00
Dr. Herbst has worked over several decades as a pioneer of personalized medicine and immunotherapy to identify biomarkers and bring novel targeted treatments and immunotherapies to patients, serving as principal investigator for numerous clinical trials testing these agents in advanced stage lung cancers.
More from AsiaOne:
PharmaTimes 08/03/2020 04:23
The collaboration will investigate the treatment's effect on advanced cancers, with a particular focus on pancreatic cancer, glioblastoma and sarcoma.
More from PharmaTimes:
A comprehensive understanding of DDR mutation-associated expression of immune regulatory genes could thus aid in expansion of current immunotherapies and predictive biomarkers for the design of patient-tailored combination treatments.
More from Clinical Cancer Research - Recent Issues (abstracts):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications